BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Bridging Real-World Evidence and AI: Unlocking Smarter, Faster Clinical Research in Asia

Having worked with pharma clients, healthcare providers, and digital platforms across the Asia-Pacific region, I’ve seen the challenges first-hand&md...

August 04, 2025 | Opinion

Precision Therapies Set to Unlock USD 1.6 Trillion in Economic Impact Across Asia-Pacific

As Asia-Pacific bears nearly half of the global cancer burden, precision medicine is emerging not only as a clinical breakthrough but also as a powerful ec...

August 04, 2025 | Interview

Everest Medicines Invests US$30.9 Million in I-Mab to Advance Next-Gen Immuno-Oncology Therapies

- Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash in I-Mab. Inclusive of I-MAB shares alread...

August 04, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

August 04, 2025 | News

Alphamab Oncology’s Bispecific ADC JSKN022 Clears IND Review in China

Alphamab Oncology announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug...

August 04, 2025 | News

Thermo Fisher Introduces MagMAX™ HMW DNA Kit to Streamline Long-Read Sequencing Workflows

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction wo...

August 01, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech

Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...

July 31, 2025 | News

Tigermed Acquires Japan’s First Imaging CRO Micron to Bolster Asia-Pacific Medical Imaging Capabilities

Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, annou...

July 30, 2025 | News

Alamar Biosciences and DZNE Join Forces to Advance Neurodegeneration Research with Ultra-Sensitive Proteomics

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease,announced a strategic collaboration with the German...

July 30, 2025 | News

Biocytogen Expands Preclinical Capabilities Across Asia and the U.S. with Over 1,000 Humanized Mouse Models

Biocytogen (HKEX: 02315), an international biotechnology company that drives new drug development with innovative technologies, announced that its pr...

July 29, 2025 | News

Suzhou’s Kintor Pharma Reports Positive Phase II Results for KX-826 in AGA Trial, Clears Path for Phase III

Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and po...

July 28, 2025 | News

Akeso Enrols First Patient in Phase III Trial of Ivonescimab for Metastatic Pancreatic Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase II...

July 24, 2025 | News

QIAGEN Expands QIAseq Portfolio with Launch of Long Read Panels to Enhance Complex Genomic Analysis

Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NGS ...

July 23, 2025 | News

Stay Connected